3 clinical trials found.
-
A Phase 2 Study of BIO 300 in Patients with COVID-19
COVID-19 is caused by a virus that triggers inflammation of the lungs. This inflammation may damage the lungs and lead to scarring. This scarring causes ... -
A Randomized Trial of Cryoprobe Versus Forceps for Transbronchial Biopsy (FROSTBITE-II)
Prospective, multi-center, randomized controlled trial in patients undergoing bronchoscopy with transbronchial biopsy for evaluation of diffuse parenchymal lung disease, lung transplant or pulmonary parenchymal lesions. -
A Phase 2 Multicenter Randomized Double-blind Placebo-controlled Study to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of TTI-101 in Participants with Idiopathic Pulmonary Fibrosis
This multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical study is designed to evaluate the safety and tolerability of 3 dose levels of TTI-101 vs placebo in ...